H. Le Roux Jooste

Executive

US·SEC (Form 4)

Ocata Therapeutics, Inc.

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 11 Feb 2016 for Ocata Therapeutics, Inc.. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

H. Le Roux Jooste: trading record in brief

One trade, one date: on 11 February 2016, H. Le Roux Jooste disclosed a transaction in Ocata Therapeutics, Inc. No broader history exists yet. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to H. Le Roux Jooste

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Ocata Therapeutics, Inc. (US)

Declarations1 total

●

H. Le Roux Jooste

SVP of Bus Development & CCOExecutives10 Feb 2016Ocata Therapeutics, Inc.

0SEC ↗

25,000 sharesCommon StockSEC:0001104659-16-095967:0

1 of 1 declaration

H. Le Roux Jooste

Insider track record

H. Le Roux Jooste: trading record in brief

Companies and markets linked to H. Le Roux Jooste

Related entities

H. Le Roux Jooste

Insider track record

H. Le Roux Jooste: trading record in brief

Companies and markets linked to H. Le Roux Jooste

Related entities